4 unchanged sentences
To date, we have not paid dividends on our common stock nor do we anticipate that we will pay dividends in the foreseeable future.
−Removed: As of December 31, 2023, we do not have any preferred stock outstanding that has any preferential dividends.
+Added: As of December 31, 2024, we did not have any preferred stock outstanding that has any preferential dividends.
Recent Sales of Unregistered Securities.
−Removed: Use of Proceeds from Registered Securities.
−Removed: The Company did not sell any of its securities during the fiscal year ended December 31, 2023 that were not registered under the Securities Act of 1933, as amended.
+Added: On December 12, 2024, the Company issued 14,001 shares of common stock to certain accredited personnel pursuant to the exercise of stock options.
+Added: On December 17, 2024, the Company issued an additional 25,758 shares of common stock to certain accredited personnel pursuant to the exercise of stock options.
+Added: These securities were issued in reliance on the exemption set forth in Section 4(a)(2) of the Securities Act of 1933, as amended.
Issuer Purchases of Equity Securities.
9 unchanged sentences
[2] Amounts in this column reflect weighted average price paid per share, which includes commissions and other expenses associated with the repurchases.
−Removed: [3] This column reflects the approximate dollar value of shares of our common stock that are available for purchase under the $4.0 million repurchase program authorized by our Board of Directors on May 5, 2022 (“2022 Repurchase Program”).
−Removed: The 2022 Repurchase Program expires in June 2025.
+Added: [3] Our Board of Directors authorized a share repurchase program on May 5, 2022 (“Repurchase Program”), which permits the Company to purchase up to an aggregate of $4.0 million in common shares over a three year period ending in June 2025.
+Added: On September 13, 2024, our Board of Directors approved an amendment to the Company’s existing share repurchase program to (i) increase the authorized aggregate amounts of shares of the Company’s common stock the Company may repurchase from $4.0 million to $6.0 million and (ii) extend the term of the Repurchase Program from May 4, 2025 to June 30, 2025.
+Added: This column reflects the approximate dollar value of shares of our common stock that are available for purchase under the Repurchase Program, as amended.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.